• About
  • Overview
    • Prescribing Info
    • Directions for Use
    • Product Fact Sheet
  • Patient Awareness and Education
  • Product Videos
  • Events
  • FAQs
• Treating DFU's
  • Diabetic Foot Ulcers
  • Efficacy and Safety
  • Patient Identification
• Reimbursement
  • Support Center
  • Insurance Verification Form

• Print Page
• Email Page

• Diabetic Foot Ulcers
• Efficacy and Safety
• Patient Identification

Patient Identification

2010 Consensus Guidelines for the Treatment of Diabetic Foot Ulcers¹

Debridement

Weekly cold steel surgical debridement and then maintained as necessary based on wound condition

Infection control

• Bacterial colonization ≠ infection
• Monitor for infection
• Infection diagnosis from clinical findings
• Culture (using appropriate technique)

Offloading

• Total contact cast (TCC)
• Instant TCC
• Offloading options

Treatment

When wound healing stalls, early adoption of advanced therapies is advocated to accelerate wound healing and decrease complications

Dermagraft Ready...

 Adequate Blood Flow

 Wound Free of Infection

 No Bone or Tendon Exposed

 Granulation Tissue

 Offloading Plan Discussed

 Dermagraft Insurance Verification Form

The Obvious Dermagraft Patient	Not-So-Obvious Dermagraft Patient
DFU Location: plantar Wound Size: 3.5 x 3.0 cm Duration: 1.5 years	DFU Location: toe Wound Size: 1.0 x 1.0 cm Duration: 3 months
DFU Location: heel Wound Size: 3.75 x 4.0 cm Duration: 4 months	DFU Location: plantar Wound Size: 2.0 x 2.0 cm Duration: 6 weeks
DFU Location: toe Wound Size: 1.5 x 1.5 cm Duration: 3 months	DFU Location: lateral Wound Size: 9.0 x 4.0 cm Duration: 8 weeks

Dermagraft may be an option for DFUs greater than 6 weeks duration.

References

1. Snyder RJ, Kirsner RS, Warriner RA, et al. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Ostomy Wound Manage. 2010;56(4 suppl):S1-S24. (Funding for this publication was provided by Advanced BioHealing.)